EMEA-002010-PIP01-16-M03
Key facts
| Invented name |
Yescarta
|
| Active substance |
Axicabtagene ciloleucel
|
| Therapeutic area |
Oncology
|
| Decision number |
P/0114/2022
|
| PIP number |
EMEA-002010-PIP01-16-M03
|
| Pharmaceutical form(s) |
Dispersion for infusion
|
| Condition(s) / indication(s) |
Treatment of mature B-cell neoplasms
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Kite Pharma EU B.V.
Tel. +1 4242091332 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|